HIV-2 is a nonpandemic form of the virus causing AIDS, and the majority of HIV-2-infected patients exhibit long-term nonprogression. The HIV-1 and HIV-2 envelope glycoproteins, the sole targets of neutralizing antibodies, share 30 to 40% identity. As a first step in understanding the reduced pathogenicity of HIV-2, we solved a 3.0-Å structure of an HIV-2 gp120 bound to the host receptor CD4, which reveals structural similarity to HIV-1 gp120 despite divergence in amino acid sequence
Acquired immunodeficiency syndrome (AIDS) and its causal agent, the human immunodeficiency virus 1 (...
More than thirty years after the discovery that Human Immunodeficiency Virus (HIV) was the causative...
CD4-immunoglobulin G2 (CD4-IgG2) incorporates four copies of the D1D2 domains of CD4 into an antibod...
HIV-2 is a nonpandemic form of the virus causing AIDS, and the majority of HIV-2-infected patients e...
AbstractThe recent determination of the structure of a complex formed between the HIV-1 glycoprotein...
AIDS (acquired immune deficiency syndrome) was discovered more than forty years ago, however, until ...
The remarkable diversity, glycosylation and conformational flexibility of the human immunodeficiency...
Efforts to design an effective antibody-based vaccine against HIV-1 would benefit from understanding...
Strategies to combat HIV-1 require structural knowledge of envelope proteins from clade C viruses, t...
AbstractSmall-angle x-ray scattering data on the unliganded full-length fully glycosylated HIV-1 gp1...
Since the discovery more than 30 years ago of human immunodeficiency virus (HIV) as the causative ag...
AbstractThe human immunodeficiency virus (HIV-1) exterior envelope glycoprotein, gp120, mediates rec...
A subset of the neutralizing anti-HIV antibodies recognize epitopes on the envelope protein gp120 of...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
Variable V1/V2 and V3 loops on human immunodeficiency virus type 1 (HIV-1) envelope-gp120 core play ...
Acquired immunodeficiency syndrome (AIDS) and its causal agent, the human immunodeficiency virus 1 (...
More than thirty years after the discovery that Human Immunodeficiency Virus (HIV) was the causative...
CD4-immunoglobulin G2 (CD4-IgG2) incorporates four copies of the D1D2 domains of CD4 into an antibod...
HIV-2 is a nonpandemic form of the virus causing AIDS, and the majority of HIV-2-infected patients e...
AbstractThe recent determination of the structure of a complex formed between the HIV-1 glycoprotein...
AIDS (acquired immune deficiency syndrome) was discovered more than forty years ago, however, until ...
The remarkable diversity, glycosylation and conformational flexibility of the human immunodeficiency...
Efforts to design an effective antibody-based vaccine against HIV-1 would benefit from understanding...
Strategies to combat HIV-1 require structural knowledge of envelope proteins from clade C viruses, t...
AbstractSmall-angle x-ray scattering data on the unliganded full-length fully glycosylated HIV-1 gp1...
Since the discovery more than 30 years ago of human immunodeficiency virus (HIV) as the causative ag...
AbstractThe human immunodeficiency virus (HIV-1) exterior envelope glycoprotein, gp120, mediates rec...
A subset of the neutralizing anti-HIV antibodies recognize epitopes on the envelope protein gp120 of...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
Variable V1/V2 and V3 loops on human immunodeficiency virus type 1 (HIV-1) envelope-gp120 core play ...
Acquired immunodeficiency syndrome (AIDS) and its causal agent, the human immunodeficiency virus 1 (...
More than thirty years after the discovery that Human Immunodeficiency Virus (HIV) was the causative...
CD4-immunoglobulin G2 (CD4-IgG2) incorporates four copies of the D1D2 domains of CD4 into an antibod...